News
Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska ...
A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...
New research shows a common over-the-counter drug may have significant benefits for people with colon and rectal cancer.
News-Medical.Net on MSN
Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...
THURSDAY, Sept. 18, 2025 (HealthDay News) — Aspirin can cut by more than half the risk that colon cancer will come back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback